{"id":"W4309228391","doi":"10.1101/2022.11.07.22282049","title":"A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling","year":2022,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Respiratory Support and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"Biomedical Advanced Research and Development Authority; University of California, San Francisco; Genentech; Maze Therapeutics; Parker Institute for Cancer Immunotherapy; National Institutes of Health; National Science Foundation; U.S. Department of Health and Human Services; Chan Zuckerberg Initiative; National Heart, Lung, and Blood Institute; U.S. Department of Defense","keywords":"ARDS; Medicine; Myeloid; Immunology; Rage (emotion); Blockade; Inflammation; Tocilizumab; Biology; Internal medicine; Lung; Receptor; Neuroscience","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000233592,0.0003189499,0.000320712,0.0001771795,0.0001205637,0.0003529625,0.0001136601,0.0001645919,0.00168375],"category_scores_gemma":[0.0001600726,0.00007794399,0.0001868686,0.0001024062,0.0002353669,0.0001183458,0.0002041566,0.00102235,0.0002874465],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002112286,"about_ca_system_score_gemma":0.0002154965,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001755223,"about_ca_topic_score_gemma":0.0003114642,"domain_scores_codex":[0.9998032,0.00003993261,0.00002112571,0.00003645659,0.00004816645,0.00005114438],"domain_scores_gemma":[0.9998623,0.000009339754,0.00005798657,0.00001102183,0.00001077136,0.00004864256],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002110893,0.0002417758,0.006212215,0.0001642761,0.00004360175,0.0001326724,0.00003293468,0.0002940914,0.9744082,0.0001442703,0.000551821,0.01566323],"study_design_scores_gemma":[0.0009581979,0.008679279,0.209984,0.00008329021,0.000247354,0.003541337,0.0002641465,0.00406966,0.7530525,0.0004230722,0.01866928,0.00002792766],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900547,0.004745903,0.00152061,0.0004266161,0.00008808768,0.00009841727,0.0008974114,0.0001589358,0.00200925],"genre_scores_gemma":[0.9971994,0.000742391,0.0006856484,0.0001210167,0.00003019835,0.00004916226,0.0004842614,0.000009617057,0.0006783364],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00168375,"threshold_uncertainty_score":0.005632699,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04127592463792078,"score_gpt":0.3180827940421829,"score_spread":0.2768068694042621,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}